Nanologica will participate in Redeye Life Science Day 2023. CEO Andreas Bhagwani will take part of an In Focus interview at 09.20. The interview will be broadcasted live on this link. For further information about the event and how to attend in person, please visit Redeyes event site.
Nanologica’s CEO Andreas Bhagwani interviewed by Redeye analyst Filip Einarsson regarding Nanologica’s first large-scale delivery to an insulin manufacturer for evaluation in production and what this means for the company going forward. Watch the video here (in Swedish).
Nanologica delivers silica to an insulin manufacturer in Asia against an order received last year. The delivery consists of silica for evaluation in full-scale production. The delivery is made against an order that was placed last year and Nanologica will provide the silica free of charge in return for being provided with results and insights into the final evaluation. The customer, which is one of the world’s largest insulin manufacturers, finances all other costs for
Intervju med vd Andreas Bhagwani gällande delårsrapporten för Q2 2023.
